CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-12-19 | WEISS MICHAEL S Director | Grant or award | +1,979,346 | 1,979,346 | ||
| 2013-12-19 | WEISS MICHAEL S Director | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 | ||
| 2013-12-19 | ROSENWALD LINDSAY A MD President and CEO | Grant or award | +1,979,346 | 4,638,347 | ||
| 2013-12-19 | Harvey Jimmie Director | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 | ||
| 2013-12-19 | BARRETT DAVID JONATHAN Director | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 | ||
| 2013-12-04 | Lu Lucy Chief Financial Officer | Purchase | +1,107 | $1.39 | $2K | 25,631 |
| 2013-11-05 | HORGAN KEVIN Chief Medical Officer | Grant or award · Options to purchase Common Stock | +200,000 | 200,000 | ||
| 2013-08-21 | Lu Lucy Chief Financial Officer | Purchase | +5,000 | $7.38 | $37K | 24,524 |
| 2013-08-21 | LOBELL J JAY Director | Purchase | +5,000 | $7.37 | $37K | 336,000 |
| 2013-07-17 | Lu Lucy Chief Financial Officer | Purchase | +4,545 | $7.90 | $36K | 19,524 |
| 2012-01-23 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +2,000 | $6.95 | $14K | 2,461,001 |
Page 12 of 12 · 231 trades